Desmoid tumor differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
Sara Mohsin (talk | contribs) |
||
Line 36: | Line 36: | ||
!Etiology (Genetic or others) | !Etiology (Genetic or others) | ||
!Histopathological findings | !Histopathological findings | ||
!Immunohistochemical staining | |||
!Benign/Malignant | |||
!Risk factors | !Risk factors | ||
!Common site of involvement | !Common site of involvement | ||
Line 56: | Line 58: | ||
* Characterized by elongated, tapered cytoplasm; elongated, vesicular, typical-appearing nuclei; and multiple small nucleoli | * Characterized by elongated, tapered cytoplasm; elongated, vesicular, typical-appearing nuclei; and multiple small nucleoli | ||
* Surrounded and separated from each other by collagen | * Surrounded and separated from each other by collagen | ||
|Positive for: | |||
* Nuclear beta-catenin (90%) | |||
* Vimentin | |||
* Alpha smooth muscle actin | |||
* Muscle actin | |||
Negative for: | |||
* Desmin | |||
* Cytokeratins | |||
* S-100 | |||
Positive antibodies for: | |||
* Smooth muscle actin | |||
* Desmin | |||
* KIT | |||
| | |||
* Benign | |||
* Local aggressive infiltration | |||
| | | | ||
* Familial adenomatous polyposis (FAP) | * Familial adenomatous polyposis (FAP) | ||
Line 91: | Line 109: | ||
* Pain or soreness caused by compressed nerves or muscles | * Pain or soreness caused by compressed nerves or muscles | ||
* Limping or other difficulty using the legs, feet, arms or hands | * Limping or other difficulty using the legs, feet, arms or hands | ||
* Decreased movement or range of motion | |||
* [[Nausea]] | * [[Nausea]] | ||
* [[Vomiting]] | * [[Vomiting]] | ||
Line 113: | Line 132: | ||
* Trisomy 20 | * Trisomy 20 | ||
|- | |- | ||
|'''[[Fibrosarcoma]]/Fibroblastic sarcoma''' | |||
| | | | ||
* Unknown precise cause | |||
* Genetics may play a role | |||
| | | | ||
* Tumor cells resemble mature fibroblasts (spindle-shaped), secreting [[collagen]], with rare [[mitoses]] | |||
* Spliting and merging cells arranged in short [[fascicles]] giving "fish bone" appearnace | |||
* Immature blood vessels (lacking [[endothelial]] cells) favor the bloodstream metastasizing | |||
* "Herringbone" pattern of cell arrangement | |||
|Strongly positive for: | |||
* Vimentin | |||
Negative for: | |||
* Desmin | |||
* Smooth muscle actin | |||
* HHF-35 | |||
* Osteocalcin | |||
* CD-68 | |||
* LCA | |||
* s100 | |||
* HMB-45 | |||
* CD-31 | |||
* CD-34 | |||
* Cytokeratin | |||
* Epithelial membrane antigen | |||
* CD-99 | |||
| | | | ||
* Malignant (with metastatic potential) | |||
| | | | ||
* Familial adenomatous polyposis | |||
* Li-Fraumeni syndrome | |||
* Neurofibromatosis type 1 | |||
* Nevoid basal cell carcinoma syndrome | |||
* Retinoblastoma | |||
* Tuberous sclerosis | |||
* Werner syndrome | |||
* Giant cell tumor | |||
* [[Enchondroma]] | |||
* [[Fibrous dysplasia]] | |||
* Bizarre parosteal osteochondromatous proliferation | |||
* Chronic osteomyelitis | |||
* [[Paget's disease]] | |||
* Radiation therapy | |||
* Surgically treated fracture | |||
* Bone infarction | |||
* Exposure to certain chemicals, such as thorium dioxide, vinyl chloride, or arsenic | |||
* Lymphedema, a swelling in the arms and legs | |||
|Primary bone malignancy involving end of long bones: | |||
* Upper end of tibia | |||
* Lower end of femur | |||
| | | | ||
* Localized Pain | |||
* Swelling | |||
* Loss of range of motion | |||
* Pain with weight-bearing | |||
* Night pain | |||
* Pathologic fracture of affected bone | |||
| | | | ||
* Moth-eaten appearance on Xray | |||
|- | |||
|Low-grade fibromyxoid sarcoma | |||
|Translocation: | |||
* t(7;18;16) | |||
| | | | ||
| | * Low to moderate cellularity | ||
* Regular medium sized nuclei | |||
* Spindle cells arranged in whorling pattern | |||
* Presence of collagenized and myxoid areas. | |||
|Positive for: | |||
* Vimentin | |||
Negative for: | |||
* Keratin | |||
* Desmin | |||
* Actin | |||
* S100 | |||
* Epithelial membrane antigen | |||
| | | | ||
* Malignant (with high metastasizing potential) | |||
| | | | ||
* | |||
| | | | ||
* Rarely, mandible | |||
| | | | ||
| | | | ||
|- | |||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
Line 137: | Line 227: | ||
| | | | ||
|- | |- | ||
| | |||
| | |||
| | | | ||
| | | |
Revision as of 16:55, 6 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Faizan Sheraz, M.D. [3]
Overview
Desmoid tumor must be differentiated from acute hematoma, lymphoma, fibrosarcoma, rhabdomyosarcoma, liposarcoma, leiomyosarcoma, neurofibroma, benign fibrous tumor and primitive neuroectodermal tumor.
Differentiating Desmoid tumor from other Diseases
- Extra-abdominal fibromatosis/desmoid tumor must be differentiated from:[1][2][3]
- Fibrosarcoma/fibroblastic sarcoma
- Low-grade fibromyxoid sarcoma[4][5]
- Gardner fibroma[6]
- Intra-abdominal fibromatosis must be differentiated from:[7]
- Gastrointestinal stromal tumor (GIST)
- Solitary fibrous tumor (SFT)
- Inflammatory myofibroblastic tumor (IMT)
- Sclerosing mesenteritis
- Retroperitoneal fibrosis due to:[8]
- Idiopathic [Ormond's disease]
- Secondary to certain drugs
- Underlying malignancy such as lymphoma
- Furthermore, desmoid tumors must be differentiated from:
Disease entity | Etiology (Genetic or others) | Histopathological findings | Immunohistochemical staining | Benign/Malignant | Risk factors | Common site of involvement | Clinical manifestations | Other associated findings |
---|---|---|---|---|---|---|---|---|
Desmoid tumor | Sporadic desmoids are associated with following mutations:
Familial desmoids/Hereditary desmoid disease is associated with:
Pediatric desmoids have following additional mutations involving:
|
Histologically, desmoid tumors consist of:
|
Positive for:
Negative for:
Positive antibodies for:
|
|
|
|
|
Desmoids may be associated with following:
|
Fibrosarcoma/Fibroblastic sarcoma |
|
|
Strongly positive for:
Negative for:
|
|
|
Primary bone malignancy involving end of long bones:
|
|
|
Low-grade fibromyxoid sarcoma | Translocation:
|
|
Positive for:
Negative for:
|
|
|
|
||
Reference
- ↑ Economou, Athanasios; Pitta, Xanthi; Andreadis, Efstathios; Papapavlou, Leonidas; Chrissidis, Thomas (2011). "Desmoid tumor of the abdominal wall: a case report". Journal of Medical Case Reports. 5 (1): 326. doi:10.1186/1752-1947-5-326. ISSN 1752-1947.
- ↑ Kasper B, Ströbel P, Hohenberger P (2011). "Desmoid tumors: clinical features and treatment options for advanced disease". Oncologist. 16 (5): 682–93. doi:10.1634/theoncologist.2010-0281. PMC 3228186. PMID 21478276.
- ↑ Carlson JW, Fletcher CD (2007). "Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature". Histopathology. 51 (4): 509–14. doi:10.1111/j.1365-2559.2007.02794.x. PMID 17711447.
- ↑ Wu X, Petrovic V, Torode IP, Chow CW (2009). "Low grade fibromyxoid sarcoma: problems in the diagnosis and management of a malignant tumour with bland histological appearance". Pathology. 41 (2): 155–60. doi:10.1080/00313020802579276. PMID 19152188.
- ↑ Bartuma H, Möller E, Collin A, Domanski HA, Von Steyern FV, Mandahl N; et al. (2010). "Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma". Cancer Genet Cytogenet. 199 (2): 143–6. doi:10.1016/j.cancergencyto.2010.02.011. PMID 20471519.
- ↑ Wehrli BM, Weiss SW, Yandow S, Coffin CM (2001). "Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis". Am J Surg Pathol. 25 (5): 645–51. PMID 11342777.
- ↑ Coffin CM, Hornick JL, Fletcher CD (2007). "Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases". Am J Surg Pathol. 31 (4): 509–20. doi:10.1097/01.pas.0000213393.57322.c7. PMID 17414097.
- ↑ Swartz RD (2009). "Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment". Am J Kidney Dis. 54 (3): 546–53. doi:10.1053/j.ajkd.2009.04.019. PMID 19515472.